Filing Details
- Accession Number:
- 0000939767-17-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-03 20:20:12
- Reporting Period:
- 2017-03-03
- Filing Date:
- 2017-03-03
- Accepted Time:
- 2017-03-03 20:20:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1648367 | J. Christopher Senner | C/O Exelixis, Inc. 210 East Grand Ave. South San Francisco CA 94080 | Evp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-03-03 | 11,000 | $22.80 | 100,398 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,783 | Indirect | By 401(k) |
Footnotes
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.80 to $22.81. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4.
- Includes 20,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 5,422 shares of common stock acquired pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. The total number of shares reported has been reduced by 20,000 shares due to prior inadvertent over-reporting of the total number of shares beneficially owned by the Reporting Person.
- Represents 1,783 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 2, 2017.